Serum AGEs and CN-1 levels were identified as independent risk factors (IRF) for DN and DR (all P&lt; 0.05).<h4>Conclusions</h4>AGEs and CN-1 may become new targets for the diagnosis and treatment of diabetic microvascular complications. The gene discussed is CNDP1; the disease is liver dysplastic nodule.